rpl-11.2 Antibody

What are the primary applications for RPL-11.2 antibodies in research?

RPL-11.2 antibodies are commonly utilized in multiple experimental techniques including:

• Western Blotting (1:2000-1:10000 dilution recommended)

• Immunoprecipitation (0.5-4.0 μg for 1.0-3.0 mg of total protein lysate)

• Immunohistochemistry (1:50-1:500 dilution recommended)

• Immunofluorescence (1:200-1:800 dilution recommended)

• Flow Cytometry (0.20 μg per 10^6 cells in a 100 μl suspension)

These applications enable researchers to detect, quantify, and visualize RPL-11.2 expression across different experimental systems .

How should RPL-11.2 antibodies be stored and handled for optimal performance?

For maximum stability and reactivity, RPL-11.2 antibodies should be stored at -20°C in appropriate buffer conditions, typically PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 . Repeated freeze-thaw cycles should be minimized to preserve antibody functionality. When working with the antibody, maintain cold chain practices and adhere to the manufacturer's specific storage requirements to ensure optimal experimental results.

What controls should be included when using RPL-11.2 antibodies for Western blotting?

When designing Western blotting experiments with RPL-11.2 antibodies, researchers should include:

• Positive control (samples known to express RPL-11.2, such as HeLa cells, HepG2 cells, or MCF-7 cells)

• Negative control (samples with RPL-11.2 knockdown or knockout)

• Loading control (housekeeping protein like GAPDH or β-actin)

• Molecular weight marker (to confirm the expected 48 kDa band for RPL-11.2)

Additionally, optimization of primary antibody concentration is critical, with typical dilutions ranging from 1:2000 to 1:10000 depending on expression levels and antibody sensitivity .

How can I optimize immunofluorescence staining protocols for RPL-11.2 detection?

For optimal immunofluorescence staining of RPL-11.2:

• Fix cells appropriately (4% paraformaldehyde for 15 minutes at room temperature is standard)

• Use adequate permeabilization (0.1-0.5% Triton X-100 for 5-10 minutes)

• Block thoroughly (5% normal serum from the species of secondary antibody origin)

• Optimize primary antibody dilution (start with 1:200-1:800 range)

• Include appropriate negative controls (primary antibody omission and isotype controls)

• Consider counterstaining nuclei with DAPI to visualize nucleolar localization

• Use confocal microscopy for precise subcellular localization assessment

What sample preparation methods are recommended for RPL-11.2 immunoprecipitation experiments?

For successful immunoprecipitation of RPL-11.2:

• Harvest cells in mid-log phase growth

• Lyse cells in non-denaturing buffer containing protease inhibitors

• Clear lysates by centrifugation (14,000 × g for 10 minutes at 4°C)

• Pre-clear with protein A/G beads to reduce non-specific binding

• Use 0.5-4.0 μg of RPL-11.2 antibody per 1.0-3.0 mg of total protein lysate

• Incubate overnight at 4°C with gentle rotation

• Capture with protein A/G beads and wash thoroughly

• Elute proteins and analyze by SDS-PAGE followed by Western blotting

How can RPL-11.2 antibodies be used to study nucleolar stress response pathways?

RPL-11.2 antibodies can be instrumental in elucidating nucleolar stress response mechanisms:

• Stress induction: Treat cells with actinomycin D (AD), which inhibits rDNA transcription , and monitor RPL-11.2 localization and expression changes

• Co-immunoprecipitation: Use RPL-11.2 antibodies to pull down protein complexes and identify interaction partners during normal and stress conditions

• Chromatin immunoprecipitation (ChIP): Examine whether RPL-11.2 associates with specific genomic regions during stress response

• Proximity ligation assay (PLA): Visualize interactions between RPL-11.2 and other stress response proteins (e.g., PHA-4/FoxA as mentioned in search result )

• Live-cell imaging: Track RPL-11.2 dynamics during stress using fluorescently tagged antibody fragments

Research has demonstrated that RPL-11.2/RPL-5 mediate nucleolar stress response, which can subsequently affect pathways like lipid accumulation regulation .

What are the considerations when using RPL-11.2 antibodies in model organisms beyond human cells?

When adapting RPL-11.2 antibody protocols for non-human models:

• Sequence homology: Verify the conservation of epitope sequences across species (the antibody shows reactivity with human, mouse, and rat samples)

• Validation: Perform species-specific validation using positive control tissues/cells and western blotting

• Fixation modifications: Adjust fixation protocols for tissue-specific requirements

• Antibody concentration: Re-optimize antibody dilutions for each new species/tissue

• Antigen retrieval: For immunohistochemistry, test both TE buffer (pH 9.0) and citrate buffer (pH 6.0) for optimal antigen recovery

• Signal amplification: Consider using signal enhancement methods for lower abundance expression

• Cross-reactivity: Test for potential cross-reactivity with other ribosomal proteins due to structural similarities

How can I integrate RPL-11.2 expression data with other -omics approaches?

For comprehensive multi-omics analysis incorporating RPL-11.2:

• RNA-seq and RPL-11.2 protein levels: Correlate transcriptomic changes with RPL-11.2 protein expression under various conditions

• Ribosome profiling: Compare ribosome profiles (as seen in the rrp-8(kun54) mutant showing decreased polysome levels) with RPL-11.2 expression patterns

• Proteomics integration: Use co-immunoprecipitation with RPL-11.2 antibodies followed by mass spectrometry to identify interaction networks

• Metabolomics correlation: Link RPL-11.2 expression with metabolic changes, particularly lipid metabolism given its role in lipid accumulation

• Data normalization: Develop appropriate normalization strategies when comparing RPL-11.2 expression across different experimental platforms

What are common issues with RPL-11.2 antibody specificity and how can they be addressed?

When encountering specificity concerns with RPL-11.2 antibodies:

• Multiple bands in Western blot: Verify if bands represent isoforms, post-translational modifications, or non-specific binding

  • Use RPL-11.2 knockdown/knockout controls to confirm specificity

  • Adjust antibody concentration and washing conditions

  • Consider using gradient gels for better separation

• Background in immunostaining: Implement strategies to enhance signal-to-noise ratio

  • Increase blocking time/concentration

  • Optimize antibody dilution (typically 1:200-1:800 for immunofluorescence)

  • Include additional washing steps with higher salt concentration

• Cross-reactivity: Confirm antibody specificity through:

  • Peptide competition assays

  • Comparison with alternative RPL-11.2 antibodies

  • Testing in systems with varied RPL-11.2 expression levels

How can I validate RPL-11.2 antibody performance in my experimental system?

For thorough antibody validation:

• Western blot: Confirm the detection of a single band at the expected molecular weight (48 kDa)

• Knockdown/knockout controls: Compare antibody signal between wild-type and RPL-11.2-depleted samples

• Multiple techniques: Validate antibody performance across different applications (WB, IP, IF, etc.)

• Positive controls: Use samples known to express RPL-11.2 (HeLa, HepG2, MCF-7 cells)

• Lot-to-lot testing: Validate new antibody lots against previously verified lots

• Alternative antibodies: Compare results with different RPL-11.2 antibodies targeting distinct epitopes

What factors influence the reproducibility of experiments using RPL-11.2 antibodies?

Key factors affecting experimental reproducibility include:

• Antibody quality: Use antibodies with proper validation and consistent performance records

• Sample preparation: Standardize cell culture conditions, lysis procedures, and protein extraction methods

• Protocol consistency: Maintain consistent incubation times, temperatures, and buffer compositions

• Technical replication: Perform technical replicates to account for procedural variability

• Biological replication: Use multiple biological samples to account for natural variation

• Quantification methods: Standardize image acquisition settings and quantification procedures

• Data analysis: Apply consistent normalization and statistical analysis methods

• Reporting standards: Document all experimental details following the antibody reporting standards

How can RPL-11.2 antibodies be utilized in studying ribosomal stress and disease models?

RPL-11.2 antibodies can provide valuable insights into disease mechanisms through:

• Cancer research: Examine RPL-11.2 expression and localization in tumor samples compared to normal tissues

• Ribosomopathies: Study RPL-11.2 dynamics in models of diseases caused by ribosomal dysfunction

• Stress response pathway: Investigate RPL-11.2/RPL-5-mediated nucleolar stress responses in disease contexts

• Therapeutic targeting: Monitor changes in RPL-11.2 expression following drug treatments that affect ribosome biogenesis

• Biomarker development: Assess RPL-11.2 as a potential biomarker for conditions involving nucleolar stress

How does RPL-11.2 function compare to other ribosomal proteins in nucleolar stress response?

Understanding the unique and overlapping functions of ribosomal proteins:

• Comparative analysis: Use antibodies against RPL-11.2, RPL-5, and other ribosomal proteins to map their distinct roles

• Double immunostaining: Visualize co-localization patterns of RPL-11.2 with other ribosomal proteins during stress

• Sequential immunoprecipitation: Determine if RPL-11.2 forms distinct or overlapping complexes with other ribosomal proteins

• Knockout/knockdown studies: Compare cellular phenotypes following depletion of RPL-11.2 versus other ribosomal proteins

• Complementation experiments: Test if overexpression of other ribosomal proteins can rescue RPL-11.2 depletion phenotypes

Research has demonstrated that RPL-11.2 works with RPL-5 to mediate nucleolar stress response, suggesting functional cooperation between specific ribosomal proteins .

What are the latest methodological advances for studying RPL-11.2 localization and dynamics?

Cutting-edge approaches for RPL-11.2 research include:

• Super-resolution microscopy: Achieve nanoscale visualization of RPL-11.2 localization within nucleolar subcompartments

• Live-cell imaging: Track RPL-11.2 dynamics in real-time using fluorescently tagged antibody fragments

• FRAP (Fluorescence Recovery After Photobleaching): Measure RPL-11.2 mobility and exchange rates in different cellular compartments

• Single-molecule tracking: Follow individual RPL-11.2 molecules to understand their movement and interactions

• Proximity labeling: Use BioID or APEX2 fused to RPL-11.2 to identify proteins in its immediate vicinity

• Optogenetics: Control RPL-11.2 localization or interactions using light-sensitive protein domains

• Cryo-electron microscopy: Visualize RPL-11.2 within ribosomal structures at near-atomic resolution